Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Brain Imaging Study Reveals Placebo’s Effect


Image: Courtesy of Andrew Leuchter et al.

Scientists have recognized for some time that people suffering from depression often experience a substantial reduction in symptoms when given a placebo. In fact, this observation has led some researchers to propose that up to 75 percent of the apparent efficacy of antidepressant medicine may actually be attributable to the placebo effect. Determining the cause of a patient’s improvement under such circumstances is no easy task. But the results of a new study may shed light on the matter. According to a report in the January issue of the American Journal of Psychiatry, depressed patients who respond to placebo treatment do exhibit a change in brain function, but one that differs from that seen in patients who respond to medication.

Using so-called quantitative electroencephalography imaging, a team of researchers at the University of California at Los Angeles studied electrical activity in the brains of 51 depressed patients receiving either placebo treatment or active medication. Patients who responded favorably to the placebo, the investigators found, showed increased activity in a region of the brain known as the prefrontal cortex. Those who responded to medication, in contrast, exhibited suppressed activity in that area. The image shown here illustrates changes in prefrontal cortex activity over time in the placebo responders group (top row) and the medication responders group (bottom row), with red indicating an increase in activity and blue-green representing a decrease. "Both treatments affect prefrontal brain function," the researchers write, "but they have distinct effects and time courses."

These results "show us that there are different pathways to improvement for people suffering from depression," team member Andrew Leuchter notes. “Medications are effective, but there may be other ways to help people get better," he adds. "If we can identify what some of the mechanisms are that help people get better with placebo, we may be able to make treatments more effective.”

Kate Wong | Scientific American
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>